LTR Pharma and Aptar Pharma have entered into a co-development agreement for Spontan The primary goal is commercialisation of ...

FMXIN002, also known as NS002, is a powder formulation of epinephrine nasal spray developed by Nasus Pharma ... FMXIN002 uses APTAR Nasal Unidose Powder device – an intuitive and easy-to-use ...

Added Carolyn Penot, Director of Operational Marketing at Aptar Pharma, “RDD Europe 2025 is a must-attend event, and this year’s Knowledge Spaces will represent the latest thinking in nasal ...